Clinical Trial Update: JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for vilobelimab in acute respiratory distress syndrome (ARDS); Cohort A is actively recruiting under the JUST BREATHE program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Vilobelimab (vilobelimab)

Snippet

Sponsor: PPD Development, LP | Conditions: Acute Respiratory Distress Syndrome (ARDS), ARDS | Phase 2 | Status: RECRUITING